Circulating sFlt-1 adheres to the receptor-binding domains of vascular endothelial growth factor (VEGF) and PIGF (a VEGF homolog), preventing their interaction with endothelial cells, inducing endothelial dysfunction (45). This evidence concerns the gene VEGFA and endothelial dysfunction.